Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veregen for vulval intraepithelial neoplasia
ISRCTN98495886Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Jan 2014
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
01
Overview
Phase 2, randomised trial of sinecatechins in vulvar intraepithelial neoplasia (VIN) (2 arms), sponsored by University of Birmingham. Started Jan 2014; status: completed.
02
Drugs
sinecatechins
03
Conditions
vulvar intraepithelial neoplasia (VIN)
Beyond the preview
Go deeper on ISRCTN98495886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN98495886.